Abbott Laboratories (FRA:ABL)
Germany
· Delayed Price · Currency is EUR 95.95
+1.72 (1.83%)
Last updated: Mar 9, 2026, 3:54 PM CET
Abbott Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 6,524 | 13,402 | 5,723 | 6,933 | 7,071 | Upgrade
|
| Depreciation & Amortization | 3,116 | 3,218 | 3,243 | 3,267 | 3,538 | Upgrade
|
| Loss (Gain) From Sale of Assets | 65 | 482 | 126 | 215 | 55 | Upgrade
|
| Stock-Based Compensation | 664 | 673 | 644 | 685 | 640 | Upgrade
|
| Change in Accounts Receivable | -652 | -691 | -356 | -68 | -383 | Upgrade
|
| Change in Inventory | 195 | -58 | -232 | -1,413 | -456 | Upgrade
|
| Change in Accounts Payable | 954 | 356 | -760 | 420 | 1,288 | Upgrade
|
| Change in Income Taxes | -5 | -8,028 | -585 | -383 | -908 | Upgrade
|
| Change in Other Net Operating Assets | -1,295 | -796 | -542 | -75 | -312 | Upgrade
|
| Operating Cash Flow | 9,566 | 8,558 | 7,261 | 9,581 | 10,533 | Upgrade
|
| Operating Cash Flow Growth | 11.78% | 17.86% | -24.21% | -9.04% | 33.31% | Upgrade
|
| Capital Expenditures | -2,171 | -2,207 | -2,202 | -1,777 | -1,885 | Upgrade
|
| Cash Acquisitions | -105 | - | -877 | - | -187 | Upgrade
|
| Divestitures | - | 1 | 40 | 48 | 134 | Upgrade
|
| Investment in Securities | -164 | -141 | -116 | -33 | -96 | Upgrade
|
| Other Investing Activities | 18 | 9 | 22 | 22 | 26 | Upgrade
|
| Investing Cash Flow | -2,422 | -2,338 | -3,133 | -1,740 | -2,008 | Upgrade
|
| Short-Term Debt Issued | - | - | 21 | 47 | - | Upgrade
|
| Long-Term Debt Issued | 5 | 223 | 2 | 7 | 4 | Upgrade
|
| Total Debt Issued | 5 | 223 | 23 | 54 | 4 | Upgrade
|
| Short-Term Debt Repaid | -115 | -100 | - | - | -204 | Upgrade
|
| Long-Term Debt Repaid | -1,504 | -660 | -2,498 | -753 | -48 | Upgrade
|
| Total Debt Repaid | -1,619 | -760 | -2,498 | -753 | -252 | Upgrade
|
| Net Debt Issued (Repaid) | -1,614 | -537 | -2,475 | -699 | -248 | Upgrade
|
| Issuance of Common Stock | 396 | 264 | 167 | 167 | 255 | Upgrade
|
| Repurchase of Common Stock | -893 | -1,295 | -1,227 | -3,795 | -2,299 | Upgrade
|
| Common Dividends Paid | -4,116 | -3,836 | -3,556 | -3,309 | -3,202 | Upgrade
|
| Other Financing Activities | -82 | - | - | - | - | Upgrade
|
| Financing Cash Flow | -6,309 | -5,404 | -7,091 | -7,636 | -5,494 | Upgrade
|
| Foreign Exchange Rate Adjustments | 71 | -96 | -23 | -122 | -70 | Upgrade
|
| Net Cash Flow | 906 | 720 | -2,986 | 83 | 2,961 | Upgrade
|
| Free Cash Flow | 7,395 | 6,351 | 5,059 | 7,804 | 8,648 | Upgrade
|
| Free Cash Flow Growth | 16.44% | 25.54% | -35.17% | -9.76% | 51.08% | Upgrade
|
| Free Cash Flow Margin | 16.68% | 15.14% | 12.61% | 17.88% | 20.08% | Upgrade
|
| Free Cash Flow Per Share | 4.23 | 3.63 | 2.89 | 4.42 | 4.83 | Upgrade
|
| Cash Interest Paid | 545 | 604 | 662 | 563 | 544 | Upgrade
|
| Cash Income Tax Paid | 1,933 | 1,723 | 1,475 | 1,864 | 1,941 | Upgrade
|
| Levered Free Cash Flow | 6,289 | 5,610 | 4,990 | 7,340 | 7,675 | Upgrade
|
| Unlevered Free Cash Flow | 6,597 | 5,959 | 5,389 | 7,689 | 8,009 | Upgrade
|
| Change in Working Capital | -803 | -9,217 | -2,475 | -1,519 | -771 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.